Abstract
Rationale:
Sporotrichosis is a dermatomycosis caused by the dimorphic fungus Sporothrix schenckii sensu lato. The traditional gold standard for the definitive diagnosis of the disease is fungal culture. Our case describes the patient diagnosed lymphocutaneous sporotrichosis through the metagenomic next-generation sequencing (mNGS) quickly.
Patient concerns:
A 53-year-old male presented with protracted multiple ulcerated lesions. The pathological analysis of his skin biopsy specimen was inflammatory reaction, routine hematological and biochemistry examinations, the imaging of heart, lung and stomach were normal.
Diagnoses:
The wounds were received debridement in our ward. Sporothrix schenckii was identified by the culture and the mNGS of the wound pus.
Interventions:
Following definitive diagnosis, oral itraconazole was administered to the patient; meanwhile, regular clinical follow-up visits and reevaluations were scheduled for continuous monitoring.
Outcomes:
The patient recovered well, and no signs of recurrence were detected during follow-up.
Lessons:
This case illustrates that mNGS, as an emerging molecular biological diagnostic technique, holds significant diagnostic value for the rapid identification of sporotrichosis. Timely and accurate diagnosis is essential for achieving favorable clinical outcomes.
Keywords: itraconazole, lymphocutaneous sporotrichosis, metagenomic next-generation sequencing (mNGS), Sporothrix globosa
1. Introduction
Sporotrichosis is a cutaneous fungal infection with a global distribution, occurring preferably in tropical and subtropical regions.[1] First identified in 1898, Sporothrix schenckii was once regarded as the exclusive etiologic agent of sporotrichosis. However, with the development of molecular biology techniques, we discovered that S. schenckii is a complex of at least 6 important species with distinct biochemical properties.[2,3] Sporothrix schenckii species complex can be isolated from saprophytes in soil,decaying wood, hay and even marine animals. The disease is mainly caused by traumatic implantation of the fungus during outdoor activities such as farming, gardening, and animal husbandry.[4] Several individuals were infected through inhalation of pathogens.[5] The disease has several clinical forms, mainly cutaneous with associated lymphadenopathy, uncommon clinical features like pulmonary or disseminated disease mostly arises in immunosuppressed individuals.[6] In China, Sporothrix globosa predominates, especially in the northeastern endemic regions.[7–9] Fungal culture is still the primary diagnostic method for sporotrichosis.[4,5] Timely recognition of infectious pathogens remains a critical clinical requirement, and metagenomic next-generation sequencing (mNGS) facilitates precise pathogen identification from clinical specimens. This case attained rapid diagnosis with fungal culture and mNGS, and oral itraconazole achieved complete remission.
2. Case presentation
A 53-year-old male living in Ningbo, a city of southeastern China. He visited us on October 14, 2021, with the chief complaint of a 5-month history of slowly enlarging, festering wounds that started on his left thumb, extended to his ipsilateral forearm 2 months later and then to his ipsilateral upper-arm. No fever, chills, headache, and weight loss had occurred. Previous treatments with antibiotics and topical ointments caused no improvement. He had a history of impaired glucose tolerance and hypertension, but no immunodeficiency diseases. He reported an accidental stab by wood chips before the onset of illness.
Physical examination revealed multiple ulcerated nodules along lymphatic tracts on the hand and forearm with chronic inflammatory changes surrounding the ulcers, accompanied by exudate and surrounding tissue hyperplasia (Figs. 1A-C). Debridement of the wounds was performed in our ward. Subsequently, for definitive identification of the pathogen, pus specimen culture and smear examination were conducted on day 1, we also sent pus specimens for mNGS test. We found yeast-like fungi by immunofluorescence staining (Fig. 2A) on day 2. On day 3, the mNGS detected Sporothrix globosa with 2652 high-confidence sequence reads that showed 99.0% identity and covered 0.83% of the Sporothrix globosa genome (National center for biotechnology information BioProject ID:PRJNA816636)(Fig. 3). Routine hematological and biochemistry investigations, including the interferon-gamma release assay, immunologic tests, acid-fast staining and modified acid-fast staining, Giemsa staining, mycobacterial culture showed normal results, thus ruling out tuberculosis, nocardiosis, cutaneous leishmaniasis and cutaneous nontuberculous mycobacterial infection. The histopathology of previous hospital showed acute and chronic inflammation associated with epithelial hyperplasia and multinucleated cell reactions, making lymphoid-associated tumors less likely. The chronic inflammatory cutaneous lesion in our patient was a fixed traumatic ulcer with sequential subcutaneous nodule development along lymphatic vessels and a poor response to anti-eczema therapies, which differs from eczema featuring recurrent pruritus, symmetric erythema, rare ulcer formation and absent lymphatic dissemination. Fungal culture of purulent exudate was performed on Sabouraud dextrose agar at 25°C for 10 days, yielding numerous dark-brown colonies exhibiting a wrinkled, leathery-velvety surface (Fig. 2B). The isolate was identified as a member of the Sporothrix schenckii species complex. On the basis of clinical manifestations and laboratory findings, a diagnosis of lymphocutaneous sporotrichosis was established.
Figure 1.

The festering wounds involving the left arm of the patient. (A–C) The wounds, in order, on the left thumb, left forearm, and left upper-arm. (D–F) The lesions, in order, on the left thumb, left forearm, and left upper arm were healed after 3 months of oral itraconazole. Red arrows: biopsy site.
Figure 2.

(A) Immunofluorescence staining showing yeast-like fungus (white arrow). (B) Sporothrix schenckii colony on Sabouraud’s glucose agar (SDA) at 25°C (blue arrows).
Figure 3.

Metagenomic next-generation sequencing result of our patient: A total of 2652 specific Sporothrix globosa sequences that covered 0.83% of the total Sporothrix globosa genome were detected by mNGS in the pus sample of the patient.
The patient started oral itraconazole (200 mg twice daily for 7 days, followed by 200 mg once daily for 3 months). The lesions achieved complete healing without exudate or discharge after 3 months of itraconazole treatment; no adverse drug reactions were noted (Figs. 1D-F). We informed the patient that effective prevention and control strategies involve consistent use of personal protective equipment, such as gloves, long-sleeve clothing and sturdy boots, to prevent traumatic puncture wounds. The patient is currently under regular follow-up.
3. Discussion
Sporothrix schenckii is a thermodimorphic fungus, exhibiting mycelial growth at 25°C (saprophytic phase) and yeast-like cell proliferation at 35 to 37°C (pathogenic phase).[10] Currently, the Sporothrix genus comprises 51 taxa, which are divided into 2 major clades: a clinical clade including S. brasiliensis, S. schenckii, S. globosa, and S. luriei and an environmental clade consisting of several species complexes (e.g., S. pallida, S. candida, S. inflata) along with numerous subtypes.[11,12] The patient of the report was infected by S. globosa, which is consistent with the predominant etiological agent of sporotrichosis in China.[7,8] Orofino-Costa et al[11] also reported that S.globosa accounts for an estimated 99.3% of human sporotrichosis cases in Asia, particularly in China.
Epidemiological investigations have demonstrated that approximately 10% to 62% of patients trace their infection back to recent penetrating trauma caused by wood splinters, plant thorns, or contaminated plant debris.[5] Accordingly, sporotrichosis is commonly referred to as “rosebush disease” or “gardener’s mycosis.” In our case, the patient was stabbed by wood chips a week before illness. It is consistent with the wood splinter injuries described in case reports by Pérez-López et al[13] from Spain and Schwalb et al[14] from Peru (Table 1). Nevertheless, both cases were caused by Sporothrix schenckii. Similar to our patient, lesions in these 2 cases all occurred on the extremities, presenting as multiple ulcerative and nodular lesions distributed along lymphatic vessels. By contrast, the case reported by Verma et al[15] from India (Table 1) featured no history of traumatic inoculation, yet the pathogen isolated was also Sporothrix schenckii, with lesions confined to the face. The case documented by Martins et al[16] from Brazil involved a patient with cat exposure, and lesions developed on the upper extremities. Sporothrix species was isolated, though exact species subtype identification was not performed.
Table 1.
Clinical characteristics of published lymphocutaneous sporotrichosis case reports.
| Author, yr | Age, sex | Country | Risk & inoculum | Sporothrix sp. | Manifestations | Diagnostic method | Treatment | Outcome |
|---|---|---|---|---|---|---|---|---|
| Perez-López et al 2023 [13] | 36, M | Spain | Farmer; trauma inoculation | Sporothrix schenckii | Multiple nodules along hand/forearm lymphatic tracts | Culture | ITZ 200 mg twice daily; L-AmB 5 mg/kg/ d for 4 months |
Recovered |
| Schwalb et al 2022[14] | 58, M | Peru | Farmer; wood splinter inoculation trauma | Sporothrix schenckii | Multiple ulcerated nodules along hand/forearm lymphatic tracts | Culture | ITZ 200 mg daily for 3 months | Recovered |
| Verma et al 2019[15] | 14, M | India | None | Sporothrix schenckii | Warty lesions on the face | Culture |
ITZ 100mg twice daily; SSKI for 4 months |
Recovered |
| Martins et al 2023 [16] |
64, F | Brazil | Contact with cats | Sporothrix species | Confluent ulceration over the upper limb | Culture | ITZ 100 mg twice daily; L-AmB 3 mg/kg/ d for 21 d | Slight functional limitation |
| Li et al 2025 [17] |
49, F | Beijing, China | None | Sporothrix schenckii | Linear nodules on the face | Culture | SSKI and terbinafine | Recovered |
| Zhang et al 2016 [18] |
59, M | Tianjin, China | Diabetes mellitus | Sporothrix globosa | Multiple ulcerated nodules along hand/forearm lymphatic tracts | Culture+molecular identification | ITZ 100 mg daily for 10 months | Recovered |
| Ruan et al 2026 [19] |
68, F | Zhejiang,China | Diabetes mellitus | Sporothrix globosa | Linear nodules on the face | Culture+molecular identification | ITZ for 3 months | Recovered |
| Ruan et al 2026[19] | 48, F | Zhejiang,China | None | Sporothrix globosa | Linear nodules on the face | Culture+molecular identification | ITZ for 3 months | Recovered |
| Shi et al 2024 [20] | 34, M | Zhejiang,China | None | Sporothrix species | Linear nodules on the face | Culture | ITZ for 3 months | Recovered |
| Yu et al 2026 [21] | 47, F | Guangzhou,China | None | Sporothrix schenckii | Multiple ulcerated nodules along hand/forearm lymphatic tracts | Culture+molecular identification | ITZ 100 mg daily for 3 months | Recovered |
Ages are reported in years, F = female, ITZ = itraconazole, L-AmB = liposomal amphotericin B, M = male, Sporothrix sp. = Sporothrix species, SSKI = saturated solution of potassium iodide.
As documented by Syed et al [1] the lymphocutaneous subtype accounts for approximately 80% of sporotrichosis cases, consistent with our patient’s presentation. Previously published lymphocutaneous sporotrichosis case reports are summarized in Table 1. Definitive diagnosis of lymphocutaneous sporotrichosis relies on detection of fungal pathogens in tissue via culture, histopathology, or molecular analysis. Reported from northern China, the cases of Li et al[17] and Zhang et al[18] were caused by Sporothrix schenckii and Sporothrix globosa, with lesions located on the face and extremities respectively.Consistent with our case, cases documented by Ruan et al[19] from Zhejiang Province in southern China were confirmed to be caused by Sporothrix globosa. Another case reported by Shi et al[20] lacked clear species identification of Sporothrix. All these previously reported patients presented facial lesions, our case presented extremity lesions but shared the same pathogen, Sporothrix globosa.Also from southern China, cases documented by Yu et al[21] in Guangzhou shared identical lesion sites (the extremities) with ours, yet the causative pathogen was Sporothrix schenckii. The cases of sporotrichosis have been predominantly reported from Northeast China,[9,22] and the region is recognized as an endemic area for this disease. However, sporotrichosis can also be detected in other regions of China. Notably, the patient in our report is from Southeast China and has no travel history to Northeast China. Clinical manifestations of sporotrichosis vary across different regions of China and overseas; therefore, timely and accurate identification of causative Sporothrix species is critical for subsequent treatment.
The differential diagnosis of cutaneous lesions includes tuberculosis, Mycobacterium marinum or Mycobacterium kansasii infection,nocardiosis, bacterial pyoderma, leishmaniasis, chromoblastomycosis, blastomycosis, and even noninfectious diseases.
Currently, mNGS exhibits higher sensitivity than conventional microbiologic tests for etiological diagnosis of infectious diseases, with particular advantages in identifying rare-pathogen infections.[12,23–26] Clinical samples for testing include skin lesion tissues, biopsy specimens, abscess aspirates, pus, synovial fluid, and cerebrospinal fluid, in addition to blood. Currently, fungal culture remains the primary diagnostic method for sporotrichosis. Rueda et al[27] and He et al[28] respectively reported the cases of disseminated cutaneous sporotrichosis diagnosed by fungal culture on day 15 and day 14, which the latter patient was misdiagnosed as histoplasmosis prior to definitive confirmationin. Giuffrida et al[29] also reported the lymphocutaneous sporotrichosis diagnosed by fungal culture. Rojas et al[30] reported the case of pulmonary sporotrichosis diagnosed by fungal culture, which was further confirmed by molecular method. In our case, we rapidly identified the pathogen and its specific subtype via mNGS performed on pus specimens.
Multiple therapeutic options are available for sporotrichosis, including potassium iodide, itraconazole, fluconazole, terbinafine, amphotericin B, and several physical therapeutic modalities. The choice of treatment depends on both the clinical presentation and the immune status of the patient.[14] Itraconazole is the preferred drug for less severe infections. Fixed cutaneous or lymphocutaneous sporotrichosis should be treated for 2 to 4 weeks after lesion resolution, with a total duration of 3 to 6 months.[11,14] This regimen was consistent with the treatment administered in our case.
4. Conclusion
In conclusion, for patients with chronic recurrent ulcerative skin lesions, the possibility of special bacterial infections should be taken into consideration by clinicians. Traditional body fluid culture remains the gold standard for the diagnosis of such infections, whereas modern diagnostic techniques, such as mNGS assays, can markedly improve the efficiency and accuracy of diagnostic identification.
Acknowledgments
We thank the patient for agreeing to let us report on this case report.
Author contributions
Formal analysis: Xiaoqing Wang.
Data curation: Jianping Xu, Yaqing Li.
Resources: Li Qin.
Writing – original draft: Xiaoqing Wang, Jing Bian, Qingsong Meng.
Writing – review & editing: Xiaoqing Wang, Shujuan Ji, Qingsong Meng.
Abbreviations:
- mNGS
- metagenomic next-generation sequencing
- SDA
- sabouraud dextrose agar
The study is supported by Medical Science Research Project of Hebei (NO. 20211162).
All participants gave written informed consent to take part in this research. In addition, explicit written permission for publication of the case details was obtained from the patient.
This case report is a retrospective analysis of a single clinical case. In accordance with the policies of the Ethics Committee of Hebei General Hospital and international guidelines (e.g., ICMJE), such case reports are exempt from formal ethics review. However, written informed consent was obtained from the patient for participation in this report and the publication of related clinical data.
The authors have no conflicts of interest to declare.
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
How to cite this article: Wang X, Bian J, Xu J, Li Y, Ji S, Qin L, Meng Q. Lymphocutaneous sporotrichosis: A case report from southeastern China and review of the literature. Medicine 2026;105:39(e50812).
Contributor Information
Xiaoqing Wang, Email: wxqing0221@163.com.
Jing Bian, Email: bianjingmh@163.com.
Jianping Xu, Email: xjpjy99@163.com.
Yaqing Li, Email: liyaqingyu@sina.com.
Shujuan Ji, Email: 823717294@qq.com.
Li Qin, Email: 982316644@qq.com.
References
- [1].Syed HA, Talati R. Sporotrichosis. StatPearls. StatPearls Publishing. Copyright © 2025, StatPearls Publishing LLC; 2025. [Google Scholar]
- [2].Paredes-Rojas A, Palma-Ramos A, Castrillón-Rivera LE, et al. Keratinocyte response to infection with sporothrix schenckii. J Fungi (Basel). 2022;8:437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Rodrigues AM, Gonçalves SS, de Carvalho JA, Borba-Santos LP, Rozental S, Camargo ZP. Current progress on epidemiology, diagnosis, and treatment of sporotrichosis and their future trends. J Fungi (Basel). 2022;8:776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Tran K, Vijayan V. Sporotrichosis. J Pediatr. 2025;278:114439. [DOI] [PubMed] [Google Scholar]
- [5].Ramírez-Soto MC. Extracutaneous sporotrichosis. Clin Microbiol Rev. 2025;38:e0014024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Toriello C, Brunner-Mendoza C, Ruiz-Baca E, Duarte-Escalante E, Pérez-Mejía A, Del Rocío Reyes-Montes M. Sporotrichosis in Mexico. Braz J Microbiol. 2021;52:49–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Cheng S, Zheng S, Zhong M, et al. Current situation of sporotrichosis in China. Future Microbiol. 2024;19:1097–106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Moussa TAA, Kadasa NMS, Al Zahrani HS, et al. Origin and distribution of Sporothrix globosa causing sapronoses in Asia. J Med Microbiol. 2017;66:560–9. [DOI] [PubMed] [Google Scholar]
- [9].Lv S, Hu X, Liu Z, Lin Y, Wu H, Li F. Clinical epidemiology of sporotrichosis in Jilin Province, China (1990-2019): a series of 4969 cases. Infect Drug Resist. 2022;15:1753–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].García-Carnero LC, Salinas-Marín R, Lozoya-Pérez NE, et al. The Heat Shock Protein 60 and Pap1 participate in the sporothrixschenckii-host interaction. J Fungi (Basel). 2021;7:960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Orofino-Costa R, Macedo PM, Rodrigues AM, Bernardes-Engemann AR. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. An Bras Dermatol. 2017;92:606–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Zhou Y, Liu Y, Wen Y. Gastrointestinal manifestations of Talaromyces marneffei infection in an HIV-infected patient rapidly verified by metagenomic next-generation sequencing: a case report. BMC Infect Dis. 2021;21:376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Perez-López I, Ruiz-Villaverde R. Long-standing lymphocutaneous sporotrichosis. Sultan Qaboos Univ Med J. 2023;23:129–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Schwalb A, Carcamo PM, Seas C. Lymphocutaneous sporotrichosis. Am J Trop Med Hyg. 2022;106:758–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Verma S, Verma G, Rattan R. Lymphocutaneous sporotrichosis of face with verrucous lesions: a case report. Indian Dermatol Online J. 2019;10:303–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Martins EB, Durães SMB, Teixeira JA, et al. Severe form of lymphocutaneous sporotrichosis: a case report. Rev Inst Med Trop Sao Paulo. 2023;65:e41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Li X, Ma DL. Linear nodules on the face: a case of facial lymphocutaneous sporotrichosis. Br J Dermatol. 2025;192:960. [DOI] [PubMed] [Google Scholar]
- [18].Zhang Y, Hagen F, Wan Z, et al. Two cases of sporotrichosis of the right upper extremity in right-handed patients with diabetes mellitus. Rev Iberoam Micol. 2016;33:38–42. [DOI] [PubMed] [Google Scholar]
- [19].Ruan G, Xia X. Facial sporotrichosis: case series, literature review and new insights about their clinical classification. Front Med (Lausanne). 2026;13:1780905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Shi W, Zheng Y, Wang H, Zhang R. Misdiagnosis of cutaneous facial sporotrichosis: an analysis of five cases. J Cosmet Dermatol. 2024;23:3000–4. [DOI] [PubMed] [Google Scholar]
- [21].Yu L, Zhang TD. Skin lesions caused by sporotrichosis. CMAJ. 2021;193:E1139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Yao L, Song Y, Cui Y, et al. Pediatric sporotrichosis in jilin province of China (2010-2016): a retrospective study of 704 cases. J. Pediatric Infect Dis Soc. 2020;9:342–8. [DOI] [PubMed] [Google Scholar]
- [23].Begovic K, Bryant L, Glenn K, Gamble S. Clinical application of metagenomic next-generation sequencing of microbial cell-free DNA in ruling out invasive fungal infection in a patient with thermal burn wounds: a case report. J Burn Care Res. 2025;46:1458–9. [DOI] [PubMed] [Google Scholar]
- [24].Zhang F, Chen J, Huang H, et al. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients. Eur J Clin Microbiol Infect Dis. 2021;40:1933–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25].Morsli M, Kerharo Q, Delerce J, Roche PH, Troude L, Drancourt M. Haemophilus influenzae meningitis direct diagnosis by metagenomic next-generation sequencing: a case report. Pathogens. 2021;10:461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [26].Wang C, Li A, Shi Q, Yu Z. Metagenomic next-generation sequencing clinches diagnosis of leishmaniasis. Lancet. 2021;397:1213. [DOI] [PubMed] [Google Scholar]
- [27].Rueda M, Torres N, Bravo F. Disseminated cutaneous sporotrichosis: an unusual case. Dermatol Online J. 2018;24:13030. [PubMed] [Google Scholar]
- [28].He Y, Ma C, Fung M, Fitzmaurice S. Disseminated cutaneous sporotrichosis presenting as a necrotic facial mass: case and review. Dermatol Online J. 2017;23:13030. [PubMed] [Google Scholar]
- [29].Giuffrida R, Caradonna E, Borgia F, Bartolotta A, Cannavò SP. Pulse itraconazole in the treatment of lymphocutaneous sporotrichosis: a case report from Southern Italy and review of the literature. Dermatol Ther. 2020;33:e13716. [DOI] [PubMed] [Google Scholar]
- [30].Rojas FD, Fernández MS, Lucchelli JM, et al. Cavitary pulmonary sporotrichosis: case report and literature review. Mycopathologia. 2017;182:1119–23. [DOI] [PubMed] [Google Scholar]
